Inspiring Resilience - Empowering Lives

Bridging Clinical Practice, Research and Patient Voice

Insightful blog from Andy Kelly about how better decisions in inflammatory arthritis are made when clinical insight and patient voice stand side by side.

Bridging Clinical Practice, Research and Patient Voice in Inflammatory Arthritis – Andy Kelly

Inflammatory arthritis (IA) is complex, fluctuating, and often invisible. While commonly associated with joint pain and stiffness, it is a systemic condition that affects physical, emotional, and social wellbeing. Across the UK, hundreds of thousands of people live with IA, navigating uncertainty, fatigue, and the wider life impact of a chronic condition.

As a clinician, educator, and patient research partner, I’ve increasingly recognised that improving outcomes in IA requires more than clinical expertise, it requires genuine collaboration with those who live with the condition(s) every day.

I am a Senior Lecturer, where I teach across undergraduate and postgraduate programmes and continue to practise clinically in musculoskeletal health. My background spans NHS practice, private care, and high-performance sport, including work with national governing bodies. This has shaped my focus on function, activity, and quality of life-priorities that strongly align with what matters most to people living with inflammatory arthritis.  

Why Patient Voice Matters

Organisations like Inflammatory Arthritis UK are leading a critical shift in how IA is understood. As a patient-led charity, its mission is centred on empowering individuals, building resilience, and ensuring that no one feels alone in their experience. This reflects a broader movement across healthcare: recognising that lived experience is not an “add-on,” but essential expertise.

Historically, research was often done on patients. Increasingly, it is being done with patients and this distinction matters.

Through my involvement in research collaborations in psoriatic arthritis, including priority setting partnerships and patient-informed trial design, I’ve seen how co-production improves both the relevance and impact of research. When people with lived experience are involved meaningfully, research asks better questions, produces more practical outcomes, and is more likely to influence care.

If there is one key lesson from my journey so far, it is this: we make better decisions when we listen.

By bringing together clinical expertise, research insight, and lived experience, we can move towards a model of care and research that truly reflects the realities of inflammatory arthritis and ultimately improves the lives of those affected.